0

Back to LabQ Clinical Exercise 6: Eculizumab in Atypical Hemolytic Uremic Syndrome: Which Tests Can Help With Diagnosis and Monitoring Effectiveness of Biologic Therapy (LQCL1806)
LabQ Clinical Exercise 6: Eculizumab in Atypical Hemolytic Uremic Syndrome: Which Tests Can Help With Diagnosis and Monitoring Effectiveness of Biologic Therapy (LQCL1806)

LabQ Clinical Exercise 6: Eculizumab in Atypical Hemolytic Uremic Syndrome: Which Tests Can Help With Diagnosis and Monitoring Effectiveness of Biologic Therapy (LQCL1806)

This is an online activity in immunology that offers 2.0 continuing education (CMLE) credit that can be used to fulfill CMP requirements.

  • List Price: $20.00
  • Member Price: $15.00
 
Want to save more?
Log into see if you qualify for a lower rate.
Members save $5.00 or more Join
Item Details:
Intended Audience: Clinical Scientists, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators.

Upon completion of this activity, you will be able to:

  • describe the role of the clinical laboratory in the diagnosis...
Back to LabQ Clinical Exercise 6: Eculizumab in Atypical Hemolytic Uremic Syndrome: Which Tests Can Help With Diagnosis and Monitoring Effectiveness of Biologic Therapy (LQCL1806)
View More View Less

Bought This Bought That ...